Valquíria Aparecida da Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Valquíria Aparecida da Silva has a total of 140 co-authors. Here are the top co-authors by number of shared publications:
- Daniel Ciampi de Andrade
Pain Center, Department of Neurology, University of São Paulo, São Paulo, Brazil
14 shared publications - Gabriel Taricani Kubota
Pain Center, Department of Neurology, University of São Paulo, São Paulo, Brazil
8 shared publications Manoel Jacobsen Teixeira
LIM 62 - Pain Center, Department of Neurology, University of São Paulo, São Paulo, Brazil
6 shared publications- Manoel Jacobsen Teixeira
Pain Center, Department of Neurology, University of São Paulo, São Paulo, Brazil
6 shared publications - Pedro Henrique Martins da Cunha
LIM-62, Pain Center, Department of Neurology, University of São Paulo, São Paulo, Brazil
5 shared publications - Alessandra Santos da Fonseca
Universidade de São Paulo, Brazil
4 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (10) , e70776
Non‐Invasive Intracranial Pressure Waveform Assessment as a Screening Test for Abnormal Lumbar Puncture Results
Background: Lumbar puncture (LP) is essential for detecting intracranial hypertension (IH) but is often non‐diagnostic and not without complications. A skull extensometer‐based non‐invasive intracranial pressure waveform assessment (NIWA) has shown promise in detecting IH in neurocritical settings. This study investigated its feasibility and accuracy among outpatient neurological individuals. Methods: This cross‐sectional study enrolled adults referred to routine outpatient LP at a tertiary‐care hospital. Subjects underwent baseline supine NIWA, then were sequentially divided (2:1:1 ratio) to: LP then follow‐up supine NIWA; follow‐up NIWA while sitting then LP; or follow‐up NIWA during Valsalva maneuver then LP. Several waveform parameters and their variation between baseline and follow‐up assessments were compared with LP results. IH was defined as LP opening pressure > 25cmH 2 O. Results: The study included 130 subjects, and 28 (21.5%) presented with IH. Dicrotic peak slope < 0.143 predicted IH with 89.5% sensitivity and 29.7% specificity (AUROC = 0.680, 95% CI 0.541–0.819). Equations derived from multivariate logistic regression models including mostly latency‐related parameters of the entire waveform and its percussion and dicrotic peaks predicted cerebrospinal fluid (CSF) chemocytology changes with AUROC = 0.661 (95% CI 0.542–0.780) and overall abnormal LP results (IH and/or altered CSF chemocytology) with 96.2% sensitivity and 24.1% specificity (AUROC = 0.696, 95% CI 0.572–0.820). Parameter changes after LP, during Valsalva maneuver, and sitting position did not improve diagnostic accuracy. Conclusions: NIWA was feasible and detected IH and CSF changes with high sensitivity among real‐world neurological outpatients. While LP remains pivotal to many cases, pre‐LP screening with NIWA may enhance diagnostic yield and mitigate complications and healthcare‐related costs.
- 14 October 2026
- Published by Wiley in European Journal of Neurology
- Vol. 33 (10) , e70776
Open AccessNon‐Invasive Intracranial Pressure Waveform Assessment as a Screening Test for Abnormal Lumbar Puncture Results
Background: Lumbar puncture (LP) is essential for detecting intracranial hypertension (IH) but is often non‐diagnostic and not without complications. A skull extensometer‐based non‐invasive intracranial pressure waveform assessment (NIWA) has shown promise in detecting IH in neurocritical settings. This study investigated its feasibility and accuracy among outpatient neurological individuals. Methods: This cross‐sectional study enrolled adults referred to routine outpatient LP at a tertiary‐care hospital. Subjects underwent baseline supine NIWA, then were sequentially divided (2:1:1 ratio) to: LP then follow‐up supine NIWA; follow‐up NIWA while sitting then LP; or follow‐up NIWA during Valsalva maneuver then LP. Several waveform parameters and their variation between baseline and follow‐up assessments were compared with LP results. IH was defined as LP opening pressure > 25cmH 2 O. Results: The study included 130 subjects, and 28 (21.5%) presented with IH. Dicrotic peak slope < 0.143 predicted IH with 89.5% sensitivity and 29.7% specificity (AUROC = 0.680, 95% CI 0.541–0.819). Equations derived from multivariate logistic regression models including mostly latency‐related parameters of the entire waveform and its percussion and dicrotic peaks predicted cerebrospinal fluid (CSF) chemocytology changes with AUROC = 0.661 (95% CI 0.542–0.780) and overall abnormal LP results (IH and/or altered CSF chemocytology) with 96.2% sensitivity and 24.1% specificity (AUROC = 0.696, 95% CI 0.572–0.820). Parameter changes after LP, during Valsalva maneuver, and sitting position did not improve diagnostic accuracy. Conclusions: NIWA was feasible and detected IH and CSF changes with high sensitivity among real‐world neurological outpatients. While LP remains pivotal to many cases, pre‐LP screening with NIWA may enhance diagnostic yield and mitigate complications and healthcare‐related costs.
- Open Access
- 5 October 2025
- Published by Elsevier in Neurophysiologie Clinique
- Vol. 55 (6) , 103109
Investigation of predictors of pain relief with high-frequency repetitive motor cortex transcranial magnetic stimulation among people with fibromyalgia
- 5 October 2025
- Published by Elsevier in Neurophysiologie Clinique
- Vol. 55 (6) , 103109
Open AccessInvestigation of predictors of pain relief with high-frequency repetitive motor cortex transcranial magnetic stimulation among people with fibromyalgia
- Open Access
- 21 August 2025
- Published by Elsevier in Brain Stimulation
- Vol. 18 (5) , 1608-1616
Transcranial direct current stimulation plus cognitive training for cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection: A randomized, double-blind, sham-controlled trial
- 21 August 2025
- Published by Elsevier in Brain Stimulation
- Vol. 18 (5) , 1608-1616
Open AccessTranscranial direct current stimulation plus cognitive training for cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection: A randomized, double-blind, sham-controlled trial
- Open Access
- 17 April 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (4) , 988
Quantitative Sensory Testing in Fibromyalgia Syndrome: A Scoping Review
Background/Objectives: Quantitative sensory testing (QST) is one of the most reliable methods for assessing Fibromyalgia Syndrome (FMS). Despite its importance, there are still controversies regarding the correct interpretation of evoked responses, as they may vary depending on the protocol, individual characteristics, disease severity, and other factors. This study aims to examine how QST has been applied as an outcome measure in FMS. Methods: We considered three databases (Medline, Embase, and Web of Science) until June 2024. From a total of 2512 studies, 126 (39 RCTs and 87 non-RCTs) were selected for full reading after assessment for risk of bias and eligibility criteria. These criteria included at least one type of QST and a clear diagnosis of fibromyalgia (FMS). Results: The results highlighted a lack of standardization in QST, as no reported protocols were followed and there was no specific number of tender points tested for FMS. Additionally, there was inconsistency in the selection of sites and types of tests conducted. Conclusions: This heterogeneity in methodology may affect the comparability and interpretation of results, underscoring the urgent need for standardized guidelines for conducting QST in fibromyalgia studies. A clear understanding of how QST has been measured could prompt a reevaluation of current approaches to FMS assessment, leading to more accurate interpretations and, ultimately, improved management of this complex condition.
- 17 April 2025
- Published by MDPI AG in Biomedicines
- Vol. 13 (4) , 988
Open AccessQuantitative Sensory Testing in Fibromyalgia Syndrome: A Scoping Review
Background/Objectives: Quantitative sensory testing (QST) is one of the most reliable methods for assessing Fibromyalgia Syndrome (FMS). Despite its importance, there are still controversies regarding the correct interpretation of evoked responses, as they may vary depending on the protocol, individual characteristics, disease severity, and other factors. This study aims to examine how QST has been applied as an outcome measure in FMS. Methods: We considered three databases (Medline, Embase, and Web of Science) until June 2024. From a total of 2512 studies, 126 (39 RCTs and 87 non-RCTs) were selected for full reading after assessment for risk of bias and eligibility criteria. These criteria included at least one type of QST and a clear diagnosis of fibromyalgia (FMS). Results: The results highlighted a lack of standardization in QST, as no reported protocols were followed and there was no specific number of tender points tested for FMS. Additionally, there was inconsistency in the selection of sites and types of tests conducted. Conclusions: This heterogeneity in methodology may affect the comparability and interpretation of results, underscoring the urgent need for standardized guidelines for conducting QST in fibromyalgia studies. A clear understanding of how QST has been measured could prompt a reevaluation of current approaches to FMS assessment, leading to more accurate interpretations and, ultimately, improved management of this complex condition.
- Open Access
- 11 March 2025
- Published by MDPI AG in Preprints.org
Quantitative Sensory Testing in Fibromyalgia Syndrome: A Scoping Review
Background/Objectives: Quantitative Sensory Testing (QST) is one of the most reliable methods for assessing Fibromyalgia Syndrome (FMS). Despite its importance, there are still controversies regarding the correct interpretation of evoked responses, as they may vary depending on the protocol, individual characteristics, disease severity, and other factors. This study aims to examine how QST has been applied as an outcome measure in FMS. Methods: We considered three databases (Medline, Embase, and Web of Science) until June 2024. From a total of 2,512 studies, 126 (39 RCTs and 87 non-RCTs) were selected for full reading after assessment for risk of bias and eligibility criteria. These criteria included at least one type of QST and a clear diagnosis of fibromyalgia (FMS). Results: Results highlighted a lack of standardization in QST, as no reported protocols were followed and there was no specific number of tender points tested for FMS. Additionally, there was inconsistency in the selection of sites and types of tests conducted. Conclusions: This heterogeneity in methodology may affect the comparability and interpretation of results, underscoring the urgent need for standardized guidelines for conducting QST in fibromyalgia studies. A clear understanding of how QST has been measured could prompt a reevaluation of current approaches to FMS assessment, leading to more accurate interpretations and, ultimately, improved management of this complex condition. Keywords: quantitative sensory testing; fibromyalgia; pain measurement; CPM; temporal summation; sensory function.
- 11 March 2025
- Published by MDPI AG in Preprints.org
Open AccessQuantitative Sensory Testing in Fibromyalgia Syndrome: A Scoping Review
Background/Objectives: Quantitative Sensory Testing (QST) is one of the most reliable methods for assessing Fibromyalgia Syndrome (FMS). Despite its importance, there are still controversies regarding the correct interpretation of evoked responses, as they may vary depending on the protocol, individual characteristics, disease severity, and other factors. This study aims to examine how QST has been applied as an outcome measure in FMS. Methods: We considered three databases (Medline, Embase, and Web of Science) until June 2024. From a total of 2,512 studies, 126 (39 RCTs and 87 non-RCTs) were selected for full reading after assessment for risk of bias and eligibility criteria. These criteria included at least one type of QST and a clear diagnosis of fibromyalgia (FMS). Results: Results highlighted a lack of standardization in QST, as no reported protocols were followed and there was no specific number of tender points tested for FMS. Additionally, there was inconsistency in the selection of sites and types of tests conducted. Conclusions: This heterogeneity in methodology may affect the comparability and interpretation of results, underscoring the urgent need for standardized guidelines for conducting QST in fibromyalgia studies. A clear understanding of how QST has been measured could prompt a reevaluation of current approaches to FMS assessment, leading to more accurate interpretations and, ultimately, improved management of this complex condition. Keywords: quantitative sensory testing; fibromyalgia; pain measurement; CPM; temporal summation; sensory function.
- Open Access
- 30 January 2025
- Published by Elsevier in Neurophysiologie Clinique
- Vol. 55 (3) , 103056
Intraoperative recordings from the posterior superior insula in awake humans with peripheral neuropathic pain
- 30 January 2025
- Published by Elsevier in Neurophysiologie Clinique
- Vol. 55 (3) , 103056
Open AccessIntraoperative recordings from the posterior superior insula in awake humans with peripheral neuropathic pain
- Open Access
- 13 January 2025
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 10 (1) , e1221
Repetitive transcranial magnetic stimulation for fibromyalgia: are we there yet?
Repetitive transcranial magnetic stimulation (rTMS) has increasingly been used to modify cortical maladaptive plastic changes shown to occur in fibromyalgia (FM) and to correlate with symptoms. Evidence for its efficacy is currently inconclusive, mainly due to heterogeneity of stimulation parameters used in trials available to date. Here, we reviewed the current evidence on the use of rTMS for FM control in the format of a narrative review, in which a systematic dissection of the different stimulation parameters would be possible. We conducted a search in Medline and Embase for controlled trials on rTMS in people with FM with at least 10 participants in each treatment arm, and treatment/follow-up of at least 3 weeks. The search identified 482 abstracts, of which 45 were screened to full review, and 11 met inclusion criteria. Six out of 11 trials were positive. The dorsolateral prefrontal cortex was the target in 218 patients (49.2%), and the primary motor cortex (M1) in 225 (50.8%). Studies targeting M1 at 10 Hz, with stimulation current delivered in the posterior-anterior, were systematically positive, frequently showing that maintenance sessions delivered weekly, and biweekly were able to maintain the analgesic effects seen after daily induction sessions. Studies assessing the effects of rTMS for FM are still marked by heterogeneity in stimulation petameters, choice of primary outcomes, and inclusion criteria. The selection of the stimulation parameters associated with significant analgesic effects is likely to benefit following larger multicenter trials and improve the overall management of pain and associated symptoms in people with FM.
- 13 January 2025
- Published by Wolters Kluwer Health in Pain Reports
- Vol. 10 (1) , e1221
Open AccessRepetitive transcranial magnetic stimulation for fibromyalgia: are we there yet?
Repetitive transcranial magnetic stimulation (rTMS) has increasingly been used to modify cortical maladaptive plastic changes shown to occur in fibromyalgia (FM) and to correlate with symptoms. Evidence for its efficacy is currently inconclusive, mainly due to heterogeneity of stimulation parameters used in trials available to date. Here, we reviewed the current evidence on the use of rTMS for FM control in the format of a narrative review, in which a systematic dissection of the different stimulation parameters would be possible. We conducted a search in Medline and Embase for controlled trials on rTMS in people with FM with at least 10 participants in each treatment arm, and treatment/follow-up of at least 3 weeks. The search identified 482 abstracts, of which 45 were screened to full review, and 11 met inclusion criteria. Six out of 11 trials were positive. The dorsolateral prefrontal cortex was the target in 218 patients (49.2%), and the primary motor cortex (M1) in 225 (50.8%). Studies targeting M1 at 10 Hz, with stimulation current delivered in the posterior-anterior, were systematically positive, frequently showing that maintenance sessions delivered weekly, and biweekly were able to maintain the analgesic effects seen after daily induction sessions. Studies assessing the effects of rTMS for FM are still marked by heterogeneity in stimulation petameters, choice of primary outcomes, and inclusion criteria. The selection of the stimulation parameters associated with significant analgesic effects is likely to benefit following larger multicenter trials and improve the overall management of pain and associated symptoms in people with FM.
- Open Access
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 47, 1-21
Effects of home-use transcranial direct current stimulation on clusters of depressive symptoms: an ancillary analysis of the PSYLECT study
The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Brazilian Journal of Psychiatry
- Vol. 47, 1-21
Open AccessEffects of home-use transcranial direct current stimulation on clusters of depressive symptoms: an ancillary analysis of the PSYLECT study
The Brazilian Journal of Psychiatry is the official publication of Brazilian Psychiatric Association (Associação Brasileira de Psiquiatria - ABP)
- Open Access
- 3 September 2024
- Published by Escola Bahiana de Medicina e Saude Publica in Brain Imaging and Stimulation
- Vol. 3, e5640
Practical video demonstration of the technique to identify the posterior superior insula orthogonal scalp projection without neuronavigation: the Fast-PSI
BACKGROUND: The posterior-superior insula (PSI) has emerged as a potential target for non-invasive brain stimulation (NIBS) in the treatment of peripheral neuropathic pain. However, current methods for identifying the PSI require expensive and time-consuming brain imaging and neuronavigation. Here, we propose the Fast-PSI method, a novel approach based on craniometry and intracranial Euclidean distances proportions comparisons between scalp landmarks, to swiftly and accurately locate the PSI projection on the scalp. METHODS: Eleven healthy participants underwent identification of the PSI and cranial landmarks (CL) MNI152 coordinates using neuronavigation. Euclidean distances between nasion and PSI (N-sPSI), nasion and inion (N-I), vertex and PSI (Cz-sPSI), and vertex and tragus (Cz-T) were calculated. Craniometric-based Euclidean distances between PSI and CL were also measured. Correction factors were developed based on the proportionality of distances. RESULTS: Mean distances’ proportions were consistent between stereotactic-based and craniometric-based measurements. Correction factors were determined as 0.67 for N-sPSI and 0.75 for Cz-sPSI. The Fast-PSI formula was established using these factors to swiftly locate the PSI projection on the scalp. Test-retest, intra- and inter-rater reliability coefficients were high, with no statistical difference compared to neuronavigated coordinates. The mean time for Fast-PSI determination was significantly shorter than traditional neuronavigation. CONCLUSION: The Fast-PSI method demonstrates high precision and reliability in identifying the PSI projection for NIBS in neuropathic pain treatment. Its rapid execution and accuracy make it a promising alternative to current techniques, potentially reducing time and resource burdens associated with neuronavigation. Further validation in clinical trials and everyday practice is warranted to assess its utility in clinical settings.
- 3 September 2024
- Published by Escola Bahiana de Medicina e Saude Publica in Brain Imaging and Stimulation
- Vol. 3, e5640
Open AccessPractical video demonstration of the technique to identify the posterior superior insula orthogonal scalp projection without neuronavigation: the Fast-PSI
BACKGROUND: The posterior-superior insula (PSI) has emerged as a potential target for non-invasive brain stimulation (NIBS) in the treatment of peripheral neuropathic pain. However, current methods for identifying the PSI require expensive and time-consuming brain imaging and neuronavigation. Here, we propose the Fast-PSI method, a novel approach based on craniometry and intracranial Euclidean distances proportions comparisons between scalp landmarks, to swiftly and accurately locate the PSI projection on the scalp. METHODS: Eleven healthy participants underwent identification of the PSI and cranial landmarks (CL) MNI152 coordinates using neuronavigation. Euclidean distances between nasion and PSI (N-sPSI), nasion and inion (N-I), vertex and PSI (Cz-sPSI), and vertex and tragus (Cz-T) were calculated. Craniometric-based Euclidean distances between PSI and CL were also measured. Correction factors were developed based on the proportionality of distances. RESULTS: Mean distances’ proportions were consistent between stereotactic-based and craniometric-based measurements. Correction factors were determined as 0.67 for N-sPSI and 0.75 for Cz-sPSI. The Fast-PSI formula was established using these factors to swiftly locate the PSI projection on the scalp. Test-retest, intra- and inter-rater reliability coefficients were high, with no statistical difference compared to neuronavigated coordinates. The mean time for Fast-PSI determination was significantly shorter than traditional neuronavigation. CONCLUSION: The Fast-PSI method demonstrates high precision and reliability in identifying the PSI projection for NIBS in neuropathic pain treatment. Its rapid execution and accuracy make it a promising alternative to current techniques, potentially reducing time and resource burdens associated with neuronavigation. Further validation in clinical trials and everyday practice is warranted to assess its utility in clinical settings.
- Open Access
- 17 July 2024
- Published by Elsevier in Neurophysiologie Clinique
- Vol. 54 (5) , 102994
Posterior insula repetitive transcranial magnetic stimulation for chronic pain in patients with Parkinson disease – pain type matters: A double-blinded randomized sham-controlled trial
- 17 July 2024
- Published by Elsevier in Neurophysiologie Clinique
- Vol. 54 (5) , 102994
Open AccessPosterior insula repetitive transcranial magnetic stimulation for chronic pain in patients with Parkinson disease – pain type matters: A double-blinded randomized sham-controlled trial